Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
North Phoenix Heart Center
mi
from
Phoenix, AZ
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
North Phoenix Heart Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Sparks Regional Medical Center
mi
from
Fort Smith, AR
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Sparks Regional Medical Center
mi
from
Fort Smith, AR
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
NEA Baptist Clinic
mi
from
Jonesboro, AR
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
NEA Baptist Clinic
mi
from
Jonesboro, AR
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Phase Care, Llc
mi
from
Alameda, CA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Phase Care, Llc
mi
from
Alameda, CA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Cardiology Consultants Of Orange County
mi
from
Anaheim, CA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Cardiology Consultants Of Orange County
mi
from
Anaheim, CA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Beaver Medical Group
mi
from
Banning, CA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Beaver Medical Group
mi
from
Banning, CA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Local Institution
mi
from
Chula Vista, CA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Local Institution
mi
from
Chula Vista, CA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Escondido Cardiology Associates, Inc.
mi
from
Escondido, CA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Escondido Cardiology Associates, Inc.
mi
from
Escondido, CA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
William D. Bowden, D.O.
mi
from
Healdsburg, CA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
William D. Bowden, D.O.
mi
from
Healdsburg, CA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
California Heart Specialists
mi
from
Huntington Beach, CA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
California Heart Specialists
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Caring Clinical Research Corporation
mi
from
Laguna Hills, CA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Caring Clinical Research Corporation
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Eisenstein, Isaac
mi
from
Lakewood, CA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Eisenstein, Isaac
mi
from
Lakewood, CA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Arvind J. Mehta, Md
mi
from
Long Beach, CA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Arvind J. Mehta, Md
mi
from
Long Beach, CA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Local Institution
mi
from
Los Alamitos, CA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Local Institution
mi
from
Los Alamitos, CA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Preciado Cardiology Incorporated
mi
from
Los Angeles, CA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Preciado Cardiology Incorporated
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
East Bay Physicians Medical Group
mi
from
Oakland, CA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
East Bay Physicians Medical Group
mi
from
Oakland, CA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
St. Joseph Heritage Medical Group
mi
from
Orange, CA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
St. Joseph Heritage Medical Group
mi
from
Orange, CA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
A.R.I. Clinical Trials, Inc.
mi
from
Redondo Beach, CA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
A.R.I. Clinical Trials, Inc.
mi
from
Redondo Beach, CA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Coastal Multi-Specialty Research
mi
from
Santa Ana, CA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Coastal Multi-Specialty Research
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Radiant Research
mi
from
Santa Rosa, CA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Radiant Research
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Harbbor-Ucla Medical Center
mi
from
Torrance, CA
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Harbbor-Ucla Medical Center
mi
from
Torrance, CA
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Rocky Mountain Cardiology
mi
from
Boulder, CO
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Rocky Mountain Cardiology
mi
from
Boulder, CO
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
South Denver Cardiology Associates
mi
from
Littleton, CO
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
South Denver Cardiology Associates
mi
from
Littleton, CO
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Drogue Medical, Llc
mi
from
Wheat Ridge, CO
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Drogue Medical, Llc
mi
from
Wheat Ridge, CO
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
The Hartford Hospital
mi
from
Hartford, CT
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
The Hartford Hospital
mi
from
Hartford, CT
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Alfieri Cardiology
mi
from
Newark, DE
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Alfieri Cardiology
mi
from
Newark, DE
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Orlando Heart Specialists
mi
from
Altamonte Springs, FL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Orlando Heart Specialists
mi
from
Altamonte Springs, FL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Palm Beach Heart Institute, Llc
mi
from
Atlantis, FL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Palm Beach Heart Institute, Llc
mi
from
Atlantis, FL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Ronald L. Walsh, Do
mi
from
Clearwater, FL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Ronald L. Walsh, Do
mi
from
Clearwater, FL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
The Heart & Vascular Institute Of Florida
mi
from
Clearwater, FL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
The Heart & Vascular Institute Of Florida
mi
from
Clearwater, FL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Cardiovascular Specialist Of South Florida
mi
from
Davie, FL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Cardiovascular Specialist Of South Florida
mi
from
Davie, FL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
David E. Perloff, Md
mi
from
Ft. Lauderdale, FL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
David E. Perloff, Md
mi
from
Ft. Lauderdale, FL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Nature Coast Clinical Research
mi
from
Inverness, FL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Nature Coast Clinical Research
mi
from
Inverness, FL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Jacksonville Heart Center
mi
from
Jacksonville, FL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Jacksonville Heart Center
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Jacksonville Center for Clinical Research
mi
from
Jacksonville, FL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Jacksonville Center for Clinical Research
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
East Coast Institute for Research
mi
from
Jacksonville, FL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
East Coast Institute for Research
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
The Cardio Vascular Center P.A.
mi
from
Lake Mary, FL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
The Cardio Vascular Center P.A.
mi
from
Lake Mary, FL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Alpha Medical Research, Llc
mi
from
Melbourne, FL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Alpha Medical Research, Llc
mi
from
Melbourne, FL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Melbourne Internal Medicine Associates (Mima)
mi
from
Melbourne, FL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Melbourne Internal Medicine Associates (Mima)
mi
from
Melbourne, FL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Mount Sinai Medical Center
mi
from
Miami Beach, FL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Mount Sinai Medical Center
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Glenn J. Barquet, Md
mi
from
Miami, FL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Glenn J. Barquet, Md
mi
from
Miami, FL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Miami Cardiology Clinical Research, L.L.C.
mi
from
Miami, FL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Miami Cardiology Clinical Research, L.L.C.
mi
from
Miami, FL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Advanced Pharma Clinical Research
mi
from
Miami, FL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Advanced Pharma Clinical Research
mi
from
Miami, FL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Mediquest Research Group
mi
from
Ocala, FL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Mediquest Research Group
mi
from
Ocala, FL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Ocala Research Institute, Inc
mi
from
Ocala, FL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Ocala Research Institute, Inc
mi
from
Ocala, FL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Florida Heart Group
mi
from
Orlando, FL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Florida Heart Group
mi
from
Orlando, FL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Orlando Heart Center
mi
from
Orlando, FL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Orlando Heart Center
mi
from
Orlando, FL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Palm Beach Gardens Research Center
mi
from
Palm Beach Gardens, FL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Palm Beach Gardens Research Center
mi
from
Palm Beach Gardens, FL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Local Institution
mi
from
Pembroke Pines, FL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Local Institution
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated:  12/18/2015
Cardiology Consultants
mi
from
Pensacola, FL
Phase III Acute Coronary Syndrome
Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome
Status: Enrolling
Updated: 12/18/2015
Cardiology Consultants
mi
from
Pensacola, FL
Click here to add this to my saved trials